TRANSFORM-1

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

October, 2024

TRANSFORM-1

Jul 2, 2024, 08:18 | Blog

Naveen Pemmaraju: Navitoclax and Ruxolitinib in Patients With Untreated Myelofibrosis

Naveen Pemmaraju shared a post on LinkedIn: “A huge shout out to all of you…

Jun 17, 2024, 07:05 | Societies

15 Posts You Should Not Miss From EHA 2024!

The European Hematology Association (EHA) Hybrid Congress or EHA2024 will took place in Madrid, Spain…

Jun 16, 2024, 14:10 | Insight

Naveen Pemmaraju: TRANSFORM-1 results randomized Phase 3 clinical trial at EHA24

Naveen Pemmaraju shared on X: "Honored to present at EHA24 today the TRANSFORM-1 results from…

All: 3 Posts: 1 - 100

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Lyda Hill Philanthropies Was Honored with the American Cancer Society Philanthropist of the Year Award

Why President Biden Values Cancer Research So Much: The Story Behind Cancer Moonshot

The 2024 NIH Director’s Awards

Tedros Adhanom Ghebreyesus Received 2024 Rebranding Africa Forum Governance Leadership Award

Special Coverage

ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023